INVARIANT CHAIN (CD74) GENE-REGULATION - ENHANCED EXPRESSION ASSOCIATED WITH ACTIVATION OF PROTEIN-KINASE C-DELTA IN A MURINE B-LYMPHOMA CELL-LINE

被引:13
作者
SHIH, NY [1 ]
FLOYDSMITH, G [1 ]
机构
[1] ARIZONA STATE UNIV,DEPT ZOOL,TEMPE,AZ 85287
关键词
PROTEIN KINASE C; INVARIANT CHAIN; TPA; MHC; CD74;
D O I
10.1016/0161-5890(95)00029-E
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The invariant chain (Ii, CD74) is a transmembrane glycoprotein that is transiently associated with the MHC class II antigens in the endoplasmic reticulum and in endocytic vesicles. An activator of protein kinase C (PKC), 12-O-tetradecanoyl-1,2-phorbol 13-acetate (TPA), was found to enhance expression of Ii mRNA in the murine B lymphoma cell line, A20, 6-48 hr following treatment. In contrast, TPA did not induce the Ii in NIH 3T3 fibroblasts. TPA addition to either cell line activated PKC. Pretreatment of A20 cells with the PKC inhibitors, staurosporine or chelerythrine chloride, for 5 or 20 min prior to addition of TPA, decreased Ii mRNA levels when compared to cells treated with TPA alone. A 20 min preincubation with the highly specific PKC inhibitor, calphostin C, completely blocked the TPA enhanced expression of the Ii suggesting that activation of PKC was responsible for TPA increased Ii mRNA levels. IFN-gamma also blocked the TPA increased Ii mRNA levels. Constitutive expression of Ii mRNA was decreased by treatment with staurosporine but not chelerythrine chloride or calphostin C, suggesting that non-PKC protein kinases may also be important for maintaining high levels of Ii mRNA in these cells. Western blot analysis using PKC isotype specific antibodies showed that A20 cells express PKC delta abundantly whereas NIH 3T3 cells express primarily PKC alpha. These data suggest that a PKC delta mediated signal transduction pathway plays a crucial role in up-regulation of the Ii.
引用
收藏
页码:643 / 650
页数:8
相关论文
共 63 条
[51]  
PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
[52]   STIMULATION OF MHC CLASS-I TRANSCRIPTION BY INTERFERON-GAMMA INVOLVES A NON-A, NON-C KINASE IN ADDITION TO PROTEIN-KINASE-C [J].
RADFORD, JE ;
WARING, JF ;
POHLMAN, JK ;
GINDER, GD .
JOURNAL OF INTERFERON RESEARCH, 1993, 13 (02) :133-141
[53]  
RAHMSDORF HJ, 1986, J IMMUNOL, V136, P2293
[54]   MHC CLASS-II REGULATORY FACTOR RFX HAS A NOVEL DNA-BINDING DOMAIN AND A FUNCTIONALLY INDEPENDENT DIMERIZATION DOMAIN [J].
REITH, W ;
HERREROSANCHEZ, C ;
KOBR, M ;
SILACCI, P ;
BERTE, C ;
BARRAS, E ;
FEY, S ;
MACH, B .
GENES & DEVELOPMENT, 1990, 4 (09) :1528-1540
[55]   REGULATION OF PROTOONCOGENES C-FOS AND C-MYC EXPRESSIONS BY PROTEIN TYROSINE KINASE, PROTEIN KINASE-C, AND CYCLIC-AMP MITOGENIC PATHWAYS IN DOG PRIMARY THYROCYTES - A POSITIVE AND NEGATIVE CONTROL BY CYCLIC-AMP ON C-MYC EXPRESSION [J].
REUSE, S ;
MAENHAUT, C ;
DUMONT, JE .
EXPERIMENTAL CELL RESEARCH, 1990, 189 (01) :33-40
[56]  
SMITH MR, 1992, J IMMUNOL, V149, P1304
[57]   STAUROSPORINE, A POTENT INHIBITOR OF PHOSPHOLIPID/CA++DEPENDENT PROTEIN-KINASE [J].
TAMAOKI, T ;
NOMOTO, H ;
TAKAHASHI, I ;
KATO, Y ;
MORIMOTO, M ;
TOMITA, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 135 (02) :397-402
[58]  
Teyton L, 1992, Trends Cell Biol, V2, P52, DOI 10.1016/0962-8924(92)90163-H
[59]   REGULATION OF MHC GENE-EXPRESSION [J].
TING, JPY ;
BALDWIN, AS .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (01) :8-16
[60]  
VIDAL K, 1993, J IMMUNOL, V151, P4642